Clinical Trial Update: Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol

View source ↗

Summary

A clinical trial update reports health-related quality of life and patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: UCB Pharma SA | Conditions: Rheumatoid Arthritis | Status: COMPLETED